All In MedTech

Device Trial Radar · NCT04566055

Assessing AlloSure Dd-cfDNA Monitoring Insights of Renal Allografts With Longitudinal Surveillance

Last checked: Nov 20, 2026Latest source record: Oct 5, 2020 (this record)Source: ClinicalTrials.govMethods & limitations

Status unknown

Status

Status unknown

Enrollment

1,000

Actual

Start

Mar 1, 2019

Primary completion

Oct 1, 2020

Study completion Oct 1, 2020

Sponsor

Lead sponsor
CareDxNot on our public-company list
Sponsor type
Industry
First posted
Sep 28, 2020

More device trials from this sponsor

Design

Study type
Observational
FDA-regulated device
Yes
Who can join
All sexes, from 12 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

Prospective Observational Multicenter Cohort. External validation of donor derived cell free DNA in Renal Transplantation. Assessing performance of dd-cfDNA as a surveillance tool and its association with clinical outcomes. Outcomes include formation of de-novo DSA, eGFR decline, performance of AlloSure dd-cfDNA in Allograft rejection.

Conditions

  • Kidney Transplant Rejection

Interventions

  • AlloSureDevice

    Patients will receive donor-derived cell-free DNA testing for surveillance and for-cause.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Validation of AlloSure in Allograft rejectionTime frame: October 2020

Locations

8 sites in 1 country. Site status is shown where the registry gives one.

  • University of Colorado Hospital

    Aurora, Colorado

  • Tampa General Hosptial

    Tampa, Florida

  • University of Maryland

    Baltimore, Maryland

5 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.